indication
as of 2026-07-01Dyskinesias
Competitive landscape projected to IV Levodopa’s launch window
Competitive set
1
0 approved · 1 pipeline
Projection timeline
actual past → guided future · protection walls overlaid
10 events
2020
2024
2028
2032
2036
2040
2044
2048
today
IV Levodopa launch window
guided / estimated ↑
actual ↓
focal / guidedapprovallabel expansiontrial readoutcongressnclustered events (click to expand)guided (dashed = directional)competitor patent cliff
Competitive set
resolved drugs with trials in this indicationdrugCompleted
Pipeline · Phase 2
Phase 22 trials
Protection—
Market size
prevalence as a range, not a number